Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During Hospitalization

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT06102720

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Mikhail Zykov (from the registry)
Registry
  • NCT NCT06102720
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06102720. Randomized; no masking; primary purpose treatment. Start 2023-01-12 (actual); primary completion 2025-01-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During Hospitalization
Acronym
COLCHIDA
Intervention (Drug)
Colchicine
Intervention (Drug)
Clopidogrel
Lead sponsor
Mikhail Zykov (class: other)

Record details

Record id
cardio:ct-nct06102720
Content hash
13698f7729792a8b8c89dcfe42f7ed089addaec6fefffb6b783bab4ccab4ca60